
Fred H. Reynolds
Examiner (ID: 8556, Phone: (571)270-7214 , Office: P/1675 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1658, 1675 |
| Total Applications | 1158 |
| Issued Applications | 386 |
| Pending Applications | 177 |
| Abandoned Applications | 614 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18970433
[patent_doc_number] => 20240050525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS
[patent_app_type] => utility
[patent_app_number] => 18/259092
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259092
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259092 | METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS | Jan 30, 2022 | Pending |
Array
(
[id] => 19121046
[patent_doc_number] => 11965016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Crystal structures comprising elastin-like peptides
[patent_app_type] => utility
[patent_app_number] => 17/588579
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 39
[patent_no_of_words] => 26751
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588579 | Crystal structures comprising elastin-like peptides | Jan 30, 2022 | Issued |
Array
(
[id] => 17760092
[patent_doc_number] => 20220233704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => MUTANTS AND DRUG CONJUGATES OF R-SPONDINS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/586258
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586258 | MUTANTS AND DRUG CONJUGATES OF R-SPONDINS AND USE THEREOF | Jan 26, 2022 | Pending |
Array
(
[id] => 17595331
[patent_doc_number] => 20220144904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Composition for and Method of Improving Tissue Performance
[patent_app_type] => utility
[patent_app_number] => 17/583549
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583549 | Composition for and Method of Improving Tissue Performance | Jan 24, 2022 | Pending |
Array
(
[id] => 18075118
[patent_doc_number] => 20220400730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR CANCER TREATMENT AND METABOLIC INTERVENTION THERAPY AND OTHER USES
[patent_app_type] => utility
[patent_app_number] => 17/579408
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579408 | COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR CANCER TREATMENT AND METABOLIC INTERVENTION THERAPY AND OTHER USES | Jan 18, 2022 | Abandoned |
Array
(
[id] => 19172469
[patent_doc_number] => 20240158443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => Compositions And Methods of Synthesizing Shape Shifting Cyclic Peptides (Sscp) And Their Use in The Identification of Novel Therapeutic Compounds
[patent_app_type] => utility
[patent_app_number] => 18/272674
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272674
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272674 | Compositions and methods of synthesizing shape shifting cyclic peptides (Sscp) and their use in the identification of novel therapeutic compounds | Jan 18, 2022 | Issued |
Array
(
[id] => 19049350
[patent_doc_number] => 20240091319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => DUAL-ADMINISTRATION METHODS FOR TREATING RESPIRATORY DISTRESS
[patent_app_type] => utility
[patent_app_number] => 18/272549
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272549
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272549 | DUAL-ADMINISTRATION METHODS FOR TREATING RESPIRATORY DISTRESS | Jan 17, 2022 | Pending |
Array
(
[id] => 18107956
[patent_doc_number] => 20230000836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
[patent_app_type] => utility
[patent_app_number] => 17/573304
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573304 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | Jan 10, 2022 | Abandoned |
Array
(
[id] => 17735005
[patent_doc_number] => 20220220464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => CHIMERIC LYSM POYLPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/572524
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572524 | CHIMERIC LYSM POYLPEPTIDES | Jan 9, 2022 | Abandoned |
Array
(
[id] => 17836454
[patent_doc_number] => 20220273759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/571283
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 168500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/571283 | PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF | Jan 6, 2022 | Abandoned |
Array
(
[id] => 18108077
[patent_doc_number] => 20230000957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/569402
[patent_app_country] => US
[patent_app_date] => 2022-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/569402 | UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME | Jan 4, 2022 | Abandoned |
Array
(
[id] => 17561789
[patent_doc_number] => 20220125938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => COMPOSITIONS AND METHODS FOR DISASSEMBLING AMYLOID FIBRILS
[patent_app_type] => utility
[patent_app_number] => 17/567667
[patent_app_country] => US
[patent_app_date] => 2022-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567667
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/567667 | COMPOSITIONS AND METHODS FOR DISASSEMBLING AMYLOID FIBRILS | Jan 2, 2022 | Abandoned |
Array
(
[id] => 19097751
[patent_doc_number] => 20240116979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHOD FOR PRODUCING LIPIDIC PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 18/269716
[patent_app_country] => US
[patent_app_date] => 2021-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269716
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269716 | METHOD FOR PRODUCING LIPIDIC PEPTIDE | Dec 23, 2021 | Pending |
Array
(
[id] => 17546759
[patent_doc_number] => 20220118100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => MONOFUNCTIONAL BRANCHED POLYETHYLENE GLYCOL AND MODIFIED BIO-RELATED SUBSTANCE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/561342
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17561342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/561342 | MONOFUNCTIONAL BRANCHED POLYETHYLENE GLYCOL AND MODIFIED BIO-RELATED SUBSTANCE THEREOF | Dec 22, 2021 | Pending |
Array
(
[id] => 18986533
[patent_doc_number] => 20240058502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => MEDICAL DEVICE, AND HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/270396
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270396
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270396 | MEDICAL DEVICE, AND HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Dec 16, 2021 | Pending |
Array
(
[id] => 17609881
[patent_doc_number] => 20220152160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => DOSING REGIMEN
[patent_app_type] => utility
[patent_app_number] => 17/553008
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 565
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553008 | DOSING REGIMEN | Dec 15, 2021 | Abandoned |
Array
(
[id] => 17704559
[patent_doc_number] => 20220204565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => Cyclic Peptide Antiviral Agents and Methods Using Same
[patent_app_type] => utility
[patent_app_number] => 17/552087
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 405
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552087
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552087 | Cyclic Peptide Antiviral Agents and Methods Using Same | Dec 14, 2021 | Abandoned |
Array
(
[id] => 19519926
[patent_doc_number] => 12121626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-22
[patent_title] => Blood coagulation-promoting silk fibroin-polypeptide electrospun membrane and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/542473
[patent_app_country] => US
[patent_app_date] => 2021-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 2255
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542473
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/542473 | Blood coagulation-promoting silk fibroin-polypeptide electrospun membrane and preparation method thereof | Dec 4, 2021 | Issued |
Array
(
[id] => 17625868
[patent_doc_number] => 20220160883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION
[patent_app_type] => utility
[patent_app_number] => 17/541636
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541636
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541636 | ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION | Dec 2, 2021 | Abandoned |
Array
(
[id] => 18861894
[patent_doc_number] => 20230416329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/039218
[patent_app_country] => US
[patent_app_date] => 2021-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 336
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039218
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039218 | A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF | Nov 28, 2021 | Pending |